|   | x      | ANNUAL      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 |
|--------|--------|------------------------------------------------------------------------------------------------|
|   |   | FOR      THE FISCAL YEAR ENDED DECEMBER 31,2008                                                |

|   | o | TRANSITION      REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF      1934 |
|--------|---|----------------------------------------------------------------------------------------------------|

| FOR      THE TRANSITION PERIOD FROM _______ TO_______ |
|-------------------------------------------------------|

| Delaware                                                                |   | 20-5655648                                      |
|-------------------------------------------------------------------------|--------|-------------------------------------------------|
| (State      or other jurisdictionof      incorporation or organization) |   | (I.R.S.      Employer Identification No.)  |

 

| Large accelerated filer  o | Accelerated filer o | Non-accelerated      filer o                                                | Smaller reporting company x |
|------------------------------------------------|-------------------------------|----------------------------------------------------------------------------------|--------------------------------------------|
|                                           |                          | (Do not check if a smaller reporting company) |                                       |

----

|                                                                                                                                   |   | PAGE   |
|----------------------------------------------------------------------------------------------------------------------------------------|--------|--------|
|                                                                                                                                   |   |   |   |   |
| PART      I                                                                                                                            |   |   |   |   |
| Forward-Looking      Information                                                                                                       |   |   | 1 |   |
| Item      1 Business                                                                                                                   |   |   | 1 |   |
| Item      1A Risk Factors                                                                                                              |   |   | 3 |   |
| Item      1B Unresolved Staff Comments                                                                                                 |   |   | 3 |   |
| Item      2 Properties                                                                                                                 |   |   | 3 |   |
| Item      3 Legal Proceedings                                                                                                          |   |   | 3 |   |
| Item      4 Submission Of Matters To A Vote Of Security Holders                                                                        |   |   | 3 |   |
|                                                                                                                                   |   |   |   |   |
| PART      II                                                                                                                           |   |   |   |   |
| Item      5 Market For Registrant’s Common Equity And Related Stockholder Matters      And Issuer Purchases Of Equity Securities |   |   | 4 |   |
| Item      6  Selected Financial Data                                                                                         |   |   | 5 |   |
| Item      7 Management’s Discussion And Analysis Of Financial Condition And Results      Of Operations                           |   |   | 5 |   |
| Item      7A  Quantitative And Qualitative Disclosures About Market      Risk                                                |   |   | 9 |   |
| Item      8  Financial Statements And Supplementary Data                                                                     |   |   | 9 |   |
| Item      9 Changes In And Disagreements With Accountants On Accounting And      Financial Disclosure                                  |   |   | 24 |   |
| Item      9A Controls And Procedures                                                                                                   |   |   | 24 |   |
| Item      9B Other Information                                                                                                         |   |   | 25 |   |
|                                                                                                                                   |   |   |   |   |
| PART      III                                                                                                                          |   |   |   |   |
| Item      10 Directors, Executive Officers and Corporate Governance                                                                    |   |   | 25 |   |
| Item      11 Executive Compensation                                                                                                    |   |   | 26 |   |
| Item      12 Security Ownership Of Certain Beneficial Owners And Management And      Related Stockholder Matters                       |   |   | 26 |   |
| Item      13 Certain Relationships And Related Transactions, And Director      Independence                                            |   |   | 28 |   |
| Item      14 Principal Accountant Fees And Services                                                                                    |   |   | 29 |   |
|                                                                                                                                   |   |   |   |   |
| PART      IV                                                                                                                           |   |   |   |   |
| Item      15 Exhibits, Financial Statement Schedule                                                                                    |   |   | 30 |   |
| Signatures                                                                                                                             |   |   |   |   |

----

|   | • |   | discuss      our future expectations;                                                                |
|--------|---------|--------|------------------------------------------------------------------------------------------------------|
|   |    |   |                                                                                                 |
|   | • |   | contain      projections of our future results of operations or of our financial      condition; and |
|   |    |   |                                                                                                 |
|   | • |   | state      other “forward-looking”information.                                           |

| ITEM      1 |   | BUSINESS. |
|-------------|--------|-----------|

----

|   | • |   | food      production;                     |
|--------|---------|--------|-------------------------------------------|
|   |    |   |                                      |
|   | • |   | agricultural      chemical companies; and |
|   |    |   |                                      |
|   | • |   | pharmaceutical      companies.            |

|   | • |   | obtaining      research and development grants;                                          |
|--------|---------|--------|------------------------------------------------------------------------------------------|
|   |    |   |                                                                                     |
|   | • |   | developing      commercially feasible products;                                          |
|   |    |   |                                                                                     |
|   | • |   | filing      and obtaining additional patents;                                            |
|   |    |   |                                                                                     |
|   | • |   | entering      into licensing, marketing or joint venture agreements;                     |
|   |    |   |                                                                                     |
|   | • |   | applying      the olfaction intellectual property to a commercially viable      product; |

----

|   | • |   | developing      and implementing a marketing plan in conjunction with a partner or      licensee;              |
|--------|---------|--------|----------------------------------------------------------------------------------------------------------------|
|   |    |   |                                                                                                           |
|   | • |   | controlling      quality and cost in the manufacturing process in conjunction with a      partner or licensee; |
|   |    |   |                                                                                                           |
|   | • |   | selling      products on a profitable basis in conjunction with a partner or licensee;      and                |
|   |    |   |                                                                                                           |
|   | • |   | structuring      an agreement that will enable us to enjoy the profits of our      products.                   |

| ITEM      1A |   | RISK      FACTORS. |
|--------------|--------|--------------------|

| ITEM      1B |   | UNRESOLVED      STAFF COMMENTS. |
|--------------|--------|---------------------------------|

| ITEM      2 |   | DESCRIPTION      OF PROPERTY. |
|-------------|--------|-------------------------------|

| ITEM      3 |   | LEGAL      PROCEEDINGS. |
|-------------|--------|-------------------------|

| ITEM      4 |   | SUBMISSION      OF MATTERS TO A VOTE OF SECURITYHOLDERS. |
|-------------|--------|----------------------------------------------------------|

----

| ITEM      5 |   | MARKET      FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER      PURCHASES OF EQUITY SECURITIES. |
|-------------|--------|-------------------------------------------------------------------------------------------------------------------------------|

|                |   |   | Price  |   |
|---------------------|--------|--------|--------|--------|
| Period              |   |   | High   |   |   |   | Low |   |
| 2008                |   |   |   |   |   |   |   |   |
| First      Quarter  |   | $      | 0.23   |   |   | $ | 0.19 |   |
| Second      Quarter |   | $      | 0.23   |   |   | $ | 0.18 |   |
| Third      Quarter  |   | $      | 0.18   |   |   | $ | 0.15 |   |
| Fourth      Quarter |   | $      | 0.15   |   |   | $ | 0.13 |   |
| 2007                |   |   |   |   |   |   |   |   |
| First      Quarter  |   | $      | 2.50   |   |   | $ | 0.22 |   |
| Second      Quarter |   | $      | 0.22   |   |   | $ | 0.17 |   |
| Third      Quarter  |   | $      | 0.24   |   |   | $ | 0.18 |   |
| Fourth      Quarter |   | $      | 0.22   |   |   | $ | 0.18 |   |

| Plan      category                                              |   | (a)Number      of securities to be issued upon exercise of outstanding options, warrants      and rights |    |   | (b)Weighted-average      exercise price of outstanding options, warrants and      rights |   |    | (c)Number      of securities remaining available for future issuance under equity      compensation plans (excluding securities reflected in column      (a)) |   |
|-----------------------------------------------------------------|--------|----------------------------------------------------------------------------------------------------------|---------|--------|------------------------------------------------------------------------------------------|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| Equity      compensation plans approved by security holders (1) |   |                                                                                                     | — |   |                                                                                     |   | — |                                                                                                                                                          |   |   | — |   |
| Equity      compensation plans not approved by security holders |   |                                                                                                     | 575,000 |   |                                                                                     | $      | 0.189   |                                                                                                                                                          |   |   | — |   |
| Total                                                           |   |                                                                                                     | 575,000 |   |                                                                                     | $      | 0.189   |                                                                                                                                                          |   |   | — |   |

----

| ITEM      6 |   | SELECTED      FINANCIAL DATA. |
|-------------|--------|-------------------------------|

| ITEM      7 |   | MANAGEMENT’S      DISCUSSION AND ANALYSIS AND RESULTS OF  OPERATIONS. |
|-------------|--------|-----------------------------------------------------------------------------|

----

----

----

07-5, “DeterminingWhether an Instrument (or an Embedded Feature) Is Indexed to an Entity's OwnStock” (“EITF 
07-5”). EITF 
07-5provides that an entity should use a two step approach to evaluate

----

| ITEM      7A |   | QUANTITATIVE      AND QUALITATIVE DISCLOSURES ABOUT MARKETRISK. |
|--------------|--------|-----------------------------------------------------------------|

| ITEM      8 |   | FINANCIAL      STATEMENTS AND SUPPLEMENTARY DATA. |
|-------------|--------|---------------------------------------------------|

|                                                                  |   |          |
|-----------------------------------------------------------------------|--------|---------------|
|                                                                  |   | Page      No. |
| Report      of Independent Registered Accounting Firm                 |   | 10            |
|                                                                  |   |          |
| Financial      Statements:                                            |   |          |
|                                                                  |   |          |
| Balance      Sheets                                                   |   | 11            |
|                                                                  |   |          |
| Statements      of Operations                                         |   | 12            |
|                                                                  |   |          |
| Statements      of Changes in Stockholders’ Equity (Deficiency) |   | 13            |
|                                                                  |   |          |
| Statements      of Cash Flows                                         |   | 14            |
|                                                                  |   |          |
| Notes      to Financial Statements                                    |   | 15            |

----

----

| ASSETS                                                                                                                                     |
|--------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                       | December      31, |   | December      31, |   |
|                                                                                                                                       | 2008 |   | 2007 |   |
|                                                                                                                                       |   |   |   |   |   |   |
| Current      Assets                                                                                                                        |   |   |   |   |   |   |
| Cash      and cash equivalents                                                                                                             |   | $ | 198,187 |   |   | $ | 42,500 |   |
| Security      deposit                                                                                                                      |   |   | 4,170 |   |   |   | - |   |
| Total      Current Assets                                                                                                                  |   |   | 202,357 |   |   |   | 42,500 |   |
|                                                                                                                                       |   |   |   |   |   |   |   |   |
| Other      Assets                                                                                                                          |   |   |   |   |   |   |   |   |
| License      and patent costs                                                                                                              |   |   | 515,722 |   |   |   | 482,507 |   |
| Less:      accumulated amortization                                                                                                        |   |   | (426,067 | ) |   |   | (370,244 | ) |
| Total      Other Assets                                                                                                                    |   |   | 89,655 |   |   |   | 112,263 |   |
|                                                                                                                                       |   |   |   |   |   |   |   |   |
| Total      Assets                                                                                                                          |   | $ | 292,012 |   |   | $ | 154,763 |   |
|                                                                                                                                       |   |   |   |   |   |   |   |   |
| LIABILITIES      AND STOCKHOLDERS' EQUITY (DEFICIENCY)                                                                                     |
| Current      Liabilities                                                                                                                   |   |   |   |   |   |   |   |   |
| Accounts      payable and accrued expenses                                                                                                 |   | $ | 125,352 |   |   | $ | 122,042 |   |
| Notes      Payable - Related Party                                                                                                         |   |   | - |   |   |   | 180,000 |   |
| Total      Current Liabilities                                                                                                             |   |   | 125,352 |   |   |   | 302,042 |   |
|                                                                                                                                       |   |   |   |   |   |   |   |   |
| Stockholders'      Equity (Deficiency)                                                                                                     |   |   |   |   |   |   |   |   |
| Common      stock — $0.0001 par value, 20,000,000 shares authorized,      12,747,644 and 7,694,542 shares outstanding |   |   | 1,275 |   |   |   | 769 |   |
| Additional      paid- in capital                                                                                                           |   |   | 1,955,791 |   |   |   | 1,000,055 |   |
| Deficit      accumulated during development stage                                                                                          |   |   | (1,790,406 | ) |   |   | (1,148,103 | ) |
| Total      Stockholders' Equity (Deficiency)                                                                                               |   |   | 166,660 |   |   |   | (147,279 | ) |
|                                                                                                                                       |   |   |   |   |   |   |   |   |
| Total      Liabilities and Stockholders' Equity (Deficiency)                                                                               |   | $ | 292,012 |   |   | $ | 154,763 |   |
|                                                                                                                                       |   |   |   |   |   |   |   |   |
| See      notes to financial statements.                                                                                                    |

----

|                                                                          |   |                    |       |   |                 |   |      | For      the period |   |
|-------------------------------------------------------------------------------|--------|-------------------------|------------|--------|----------------------|--------|-----------|---------------------|--------|
|                                                                          |   |                    |       |   |                 |   |      | April      10, 2000 |   |
|                                                                          |   |                    |       |   |                 |   |      | (Commencement       |   |
|                                                                          |   | For      the Years      |       |   | of      Business)    |   |
|                                                                          |   | Ended      December 31, |       |   | to      December 31, |   |
|                                                                          |   | 2008                    |       |   | 2007                 |   |      | 2008                |   |
|                                                                          |   |                    |       |   |                 |   |      |                |   |
| Revenues                                                                      |   | $                       | -          |   |                 | $      | -         |                |   | $ | - |   |
| Direct      costs                                                             |   |                    | -          |   |                 |   | -         |                |   |   | - |   |
|                                                                          |   |                    |       |   |                 |   |      |                |   |   |   |   |
| Income      after direct costs                                                |   |                    | -          |   |                 |   | -         |                |   |   | - |   |
|                                                                          |   |                    |       |   |                 |   |      |                |   |   |   |   |
| Operating      expenses:                                                      |   |                    |       |   |                 |   |      |                |   |   |   |   |
| General      and administrative                                               |   |                    | 582,372    |   |                 |   | 237,431   |                |   |   | 1,349,829 |   |
| Amortization      of license and patent costs                                 |   |                    | 55,823     |   |                 |   | 38,711    |                |   |   | 426,067 |   |
|                                                                          |   |                    | 638,195    |   |                 |   | 276,142   |                |   |   | 1,775,896 |   |
| Other      (income) expense:                                                  |   |                    |       |   |                 |   |      |                |   |   |   |   |
|                                                                          |   |                    |       |   |                 |   |      |                |   |   |   |   |
| Interest      (income)                                                        |   |                    | (2,412     | )      |                 |   | -         |                |   |   | (2,412 | ) |
| Interest      and financing expense                                           |   |                    | 6,520      |   |                 |   | 10,402    |                |   |   | 16,922 |   |
|                                                                          |   |                    | 4,108      |   |                 |   | 10,402    |                |   |   | 14,510 |   |
|                                                                          |   |                    |       |   |                 |   |      |                |   |   |   |   |
|                                                                          |   |                    |       |   |                 |   |      |                |   |   |   |   |
| Net      loss before provision for income taxes                               |   |                    | (642,303   | )      |                 |   | (286,544  | )                   |   |   | (1,790,406 | ) |
|                                                                          |   |                    |       |   |                 |   |      |                |   |   |   |   |
| Income      taxes                                                             |   |                    | -          |   |                 |   | -         |                |   |   | - |   |
|                                                                          |   |                    |       |   |                 |   |      |                |   |   |   |   |
| Net      loss                                                                 |   | $                       | (642,303   | )      |                 | $      | (286,544  | )                   |   | $ | (1,790,406 | ) |
|                                                                          |   |                    |       |   |                 |   |      |                |   |   |   |   |
| Basic      and diluted loss per share                                         |   | $                       | (0.06      | )      |                 | $      | (0.04     | )                   |   |   |   |   |
| Weighted      average shares outstanding — basic and dilutive |   |                    | 10,317,714 |   |                 |   | 7,694,542 |                |   |   |   |   |

----

|                                                                                              |   | Common      Stock |       |   | Subscription |   |   | AdditionalPaid-in |   |   | Accumulated |   |   |    |      |
|---------------------------------------------------------------------------------------------------|--------|-------------------|------------|--------|--------------|--------|--------|-------------------|--------|--------|-------------|--------|--------|---------|-----------|
|                                                                                              |   | Shares            |       |   | Amount       |   |   | Receivable        |   |   | Capital     |   |   | Deficit |      |   | Total |   |
| Balance      - April 10, 2000 (Commencement of Predecessor Business)                              |   |              | -          |   |         | $      | -      |              |   | $      | -           |   |   | $       | -         |   |   | $ | - |   |   | $ | - |   |
| Net      loss                                                                                     |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (47,763 | ) |   |   | (47,763 | ) |
| Balance      - December 31, 2000                                                                  |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (47,763 | ) |   |   | (47,763 | ) |
| Net      loss                                                                                     |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (63,169 | ) |   |   | (63,169 | ) |
| Balance      - December 31, 2001                                                                  |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (110,932 | ) |   |   | (110,932 | ) |
| Net      loss                                                                                     |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (65,936 | ) |   |   | (65,936 | ) |
| Balance      - December 31, 2002                                                                  |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (176,868 | ) |   |   | (176,868 | ) |
| Net      loss                                                                                     |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (77,083 | ) |   |   | (77,083 | ) |
| Balance      - December 31, 2003                                                                  |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (253,951 | ) |   |   | (253,951 | ) |
| Net      loss                                                                                     |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (109,169 | ) |   |   | (109,169 | ) |
| Balance      - December 31, 2004                                                                  |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (363,120 | ) |   |   | (363,120 | ) |
| Net      loss                                                                                     |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (60,870 | ) |   |   | (60,870 | ) |
| Balance      - December 31, 2005                                                                  |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (423,990 | ) |   |   | (423,990 | ) |
| Net      loss                                                                                     |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (320,747 | ) |   |   | (320,747 | ) |
| Balance      - October 2, 2006                                                                    |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (744,737 | ) |   |   | (744,737 | ) |
| Issuance      of common stock - October 3, 2006                                                   |   |              | 7,694,542  |   |         |   | 769    |              |   |   | (769        | )      |   |    | -         |   |   |   | - |   |   |   | - |   |
| Additional      contribution of capital - October 10, 2006                                        |   |              |       |   |         |   |   |              |   |   | 769         |   |   |    | 249,231   |   |   |   |   |   |   |   | 250,000 |   |
| Contribution      to capital of License costs and assumption of liability - October 10,      2006 |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | 749,334   |   |   |   | - |   |   |   | 749,334 |   |
| Net      loss                                                                                     |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (116,822 | ) |   |   | (116,822 | ) |
| Balance      - December 31, 2006                                                                  |   |              | 7,694,542  |   |         |   | 769    |              |   |   | -           |   |   |    | 998,565   |   |   |   | (861,559 | ) |   |   | 137,775 |   |
| Stock-based      compensation expense                                                             |   |              |       |   |         |   |   |              |   |   |        |   |   |    | 1,490     |   |   |   | - |   |   |   | 1,490 |   |
| Net      loss                                                                                     |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (286,544 | ) |   |   | (286,544 | ) |
| Balance      - December 31, 2007                                                                  |   |              | 7,694,542  |   |         |   | 769    |              |   |   | -           |   |   |    | 1,000,055 |   |   |   | (1,148,103 | ) |   |   | (147,279 | ) |
| Issuance      of common stock                                                                     |   |              | 5,053,102  |   |         |   | 506    |              |   |   | -           |   |   |    | 927,194   |   |   |   | - |   |   |   | 927,700 |   |
| Stock-based      compensation expense                                                             |   |              |       |   |         |   |   |              |   |   |        |   |   |    | 28,542    |   |   |   |   |   |   |   | 28,542 |   |
| Net      loss                                                                                     |   |              | -          |   |         |   | -      |              |   |   | -           |   |   |    | -         |   |   |   | (642,303 | ) |   |   | (642,303 | ) |
| Balance-      December 31, 2008                                                                   |   |              | 12,747,644 |   |         | $      | 1,275  |              |   | $      | -           |   |   | $       | 1,955,791 |   |   | $ | (1,790,406 | ) |   | $ | 166,660 |   |

----

|                                                                                           |   |              |     |   |              |   |     | For the period |   |
|------------------------------------------------------------------------------------------------|--------|-------------------|----------|--------|-------------------|--------|----------|--------------------------|--------|
|                                                                                           |   |              |     |   |              |   |     | April 10, 2000 |   |
|                                                                                           |   |              |     |   |              |   |     | (Commencement            |   |
|                                                                                           |   | For the      |     |   | of Business) |   |
|                                                                                           |   | Year ended   |     |   | Through           |   |
|                                                                                           |   | December      31, |     |   | December      31  |   |
|                                                                                           |   | 2008              |     |   | 2007              |   |     | 2008                     |   |
|                                                                                           |   |              |     |   |              |   |     |                     |   |
| Cash      flows from operating activities                                                      |   |              |     |   |              |   |     |                     |   |
| Net      loss                                                                                  |   | $                 | (642,303 | )      |              | $      | (286,544 | )                        |   | $ | (1,790,406 | ) |
| Adjustments      to reconcile net loss to net cash provided by operating      activities:      |   |              |     |   |              |   |     |                     |   |   |   |   |
| Stock-based      compensation expense                                                          |   |              | 28,542   |   |              |   | 1,490    |                     |   |   | 30,032 |   |
| Amortization                                                                                   |   |              | 55,823   |   |              |   | 38,711   |                     |   |   | 426,067 |   |
| Changes      in operating assets and liabilities                                               |   |              |     |   |              |   |     |                     |   |   |   |   |
| Increase in      Security Deposits                                                        |   |              | (4,170   | )      |              |   | —  |                     |   |   | (4,170 | ) |
| Increase in      accounts payable and accrued expenses                                    |   |              | 11,475   |   |              |   | 82,832   |                     |   |   | 442,226 |   |
| Net      cash used in operating activities                                                     |   |              | (550,633 | )      |              |   | (163,511 | )                        |   |   | (896,251 | ) |
|                                                                                           |   |              |     |   |              |   |     |                     |   |   |   |   |
| Cash      flows from investing activities                                                      |   |              |     |   |              |   |     |                     |   |   |   |   |
| Investment      in patents                                                                     |   |              | (33,215  | )      |              |   | (41,882  | )                        |   |   | (75,097 | ) |
| Net      cash used in investing activities                                                     |   |              | (33,215  | )      |              |   | (41,882  | )                        |   |   | (75,097 | ) |
|                                                                                           |   |              |     |   |              |   |     |                     |   |   |   |   |
| Cash      flows from financing activities                                                      |   |              |     |   |              |   |     |                     |   |   |   |   |
| (Repayment)      proceeds of notes payable - related parties                                   |   |              | (25,325  | )      |              |   | 180,000  |                     |   |   | 154,675 |   |
| Proceeds      from due to related party                                                        |   |              | 106,914  |   |              |   | —  |                     |   |   | 106,914 |   |
| Proceeds      from issuance of common stock, net of offering costs                             |   |              | 657,946  |   |              |   | —  |                     |   |   | 907,946 |   |
| Net      cash provided by financing activities                                                 |   |              | 739,535  |   |              |   | 180,000  |                     |   |   | 1,169,535 |   |
|                                                                                           |   |              |     |   |              |   |     |                     |   |   |   |   |
| Increase      in cash and cash equivalents                                                     |   |              | 155,687  |   |              |   | (25,393  | )                        |   |   | 198,187 |   |
| Cash      and cash equivalents — beginning of period                                |   |              | 42,500   |   |              |   | 67,893   |                     |   |   | — |   |
|                                                                                           |   |              |     |   |              |   |     |                     |   |   |   |   |
| Cash      and cash equivalents — end of period                                      |   | $                 | 198,187  |   |              | $      | 42,500   |                     |   | $ | 198,187 |   |
|                                                                                           |   |              |     |   |              |   |     |                     |   |   |   |   |
| Non-cash      from financing activities:                                                       |   |              |     |   |              |   |     |                     |   |   |   |   |
| Assumption      of liability by Sentigen Holding Corp.                                    |   | $                 | —  |   |              | $      | —  |                     |   | $ | 308,709 |   |
| Stock      of Sentigen Holding Corp. issued for license costs                                  |   | $                 | —  |   |              | $      | —  |                     |   | $ | 440,625 |   |
|                                                                                           |   |              |     |   |              |   |     |                     |   |   |   |   |
| Conversion      of notes payable ($154,675) and accrued interest ($8,165) to common      stock |   | $                 | 162,840  |   |              | $      | —  |                     |   | $ | 162,840 |   |
|                                                                                           |   |              |     |   |              |   |     |                     |   |   |   |   |
| Conversion      of due to related party for common stock                                       |   | $                 | 106,914  |   |              | $      | —  |                     |   | $ | 106,914 |   |

----

----

| 3. Summary of      Significant Accounting Policies  |
|----------------------------------------------------------|

|   | a. | Cash and Cash Equivalents      – Cash and cash equivalents include liquid investments with      maturities of three months or less at the time of  purchase. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | b.     | Concentration of Credit Risk - Financial      instruments that potentially subject the Company to concentrations of      credit risk consist principally of cash and accounts      receivable.  The Company maintains its cash accounts at high      quality financial institutions with balances, at times, in excess of      federally insured limits. As of December 31, 2008, the Company had no cash      balances in excess of federally insured limits. Management believes that      the financial institutions that hold the Company’s deposits are      financially sound and therefore pose minimal credit risk. In October 2008,      Congress temporarily increased FDIC deposit insurance from $100,000 to      $250,000 per depositor through December 31, 2009.                                                                                                                                                                                                                                                                                                                                                                                         |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|   | c.     | License and Patent Costs      – The costs of intangible assets that are purchased from others for      use in research and development activities and that have alternative      future uses (in research and development projects or otherwise) are      accounted for in accordance with FASB Statement No. 142, “Goodwill and      Other Intangible Assets.” The amortization of those intangible assets used      in research and development activities is a research and development cost.      However, the costs of intangibles that are purchased from others for a      particular research and development project and that have no alternative      future uses (in other research and development projects or otherwise) and      therefore no separate economic values are research and development costs      at the time the costs are incurred. We determined that the licensing costs      arising from our exclusive licensing agreement with The Trustees of      Columbia University have alternative future uses. These costs have been      capitalized and are being amortized on a straight-line basis through April      2010 (see Note 6). |

|   | d. | Impairment – Intangible      and long-lived assets are reviewed for impairment whenever events or      changes in circumstances indicate that the carrying amount of the assets      may not be fully recoverable. A review for impairment includes comparing      the carrying value of an asset to an estimate of the undiscounted net      future cash inflows over the life of the asset or fair market value. An      asset is considered to be impaired when the carrying value exceeds the      calculation of the undiscounted net future cash inflows or fair market      value. An impairment loss is defined as the amount of the excess of the      carrying value over the fair market value of the asset. We believe that      none of our intangible and long-lived assets are impaired as of December      31, 2008 (see Note 6). |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | e.     | Estimates – The      preparation of financial statements in conformity with generally accepted      accounting principles requires management to make estimates and      assumptions that affect the reported amounts of assets and liabilities and      disclosure of contingent assets and liabilities at the dates of the      financial statements and the reported amounts of revenues and expenses      during the reporting periods. Actual results could differ from those      estimates. |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

|   | f. | Income Taxes – Certain      income and expense items are accounted for differently for financial      reporting and income tax purposes. Deferred tax assets and liabilities are      determined based on the difference between the financial statement and      income tax basis of assets and liabilities and the tax effect of net      operating loss and tax credit carry-forwards applying the enacted      statutory tax rates in effect for the year in which the differences are      expected to reverse. Valuation allowances are established if it is      determined to be more likely than not that deferred tax assets will not be      recovered.  The Company recognized interest and penalties, if      any, related to uncertain tax positions as income tax    expense. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | g. | Loss Per Share – The      accompanying financial statements include loss per share calculated as      required by FASB Statement No. 128 “Earnings Per Share” on a “pro-forma”      basis as if we were a separate entity from the period April 10, 2000      (commencement of business) until October 3, 2006 (our date of      incorporation). Basic loss per share is calculated by dividing net loss by      the weighted average number of shares of common stock outstanding. Diluted      loss per share include the effects of securities convertible into common      stock, consisting of stock options, to the extent such conversion would be      dilutive. FASB Statement No. 128 prohibits adjusting the denominator of      diluted Earnings Per Share for additional potential common shares when a      net loss from continuing operations is reported. The assumed exercise of      common stock equivalents was not utilized for the twelve months ended      December 31, 2008 since the effect would be anti-dilutive. As of December      31, 2008, 575,000 options were outstanding of which 458,334 were      exercisable. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | h.     | Fair Value of Financial      Instruments – The carrying value of cash and cash equivalents and      accounts payable and accrued expenses approximates fair value because of      the short-term maturity of those instruments. The carrying amount of the      Company’s notes payable approximate fair value because the effective yield      of such instruments, which includes the effects of contractual interest      rates taken together with any discounts, is consistent with current market      rates of interest for instruments of comparable credit    risk.                                                                                                                                                                                                                         |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|   |   | On      January 1, 2008, the Company adopted Financial Accounting Standards Board      (“FASB”) SFAS No. 157, “Fair Value Measurements” (“SFAS 157. There      was no impact on the Company’s financial position, results of operation or      cash flows as of December 31, 2008 and for the year then ended as a result      of FAS 157. On      January 1, 2008, the Company adopted Statement of Financial      Accounting Standards No. 159, “The Fair Value Option for Financial      Assets and Financial Liabilities (“FAS 159”). There was no impact on the      Company’s financial position, results of operation or cash flows as of      December 31, 2008 and for the year then ended as a result of FAS      159. |

|   | i.     | Stock-Based Compensation–      Stock-based compensation expense represents share-based payment awards      granted subsequent to December 31, 2005, based upon the grant date fair      value estimated in accordance with the provisions of SFAS 123R. The      Company recognizes compensation expense for stock option awards on a      straight-line basis over the requisite service period of the award.      Stock-based compensation expense is recognized based upon awards      ultimately expected to vest, reduced for estimated forfeitures. SFAS 123R      requires forfeitures to be estimated at the time of grant and revised, if      necessary, in subsequent periods if actual forfeitures differ from those      estimates.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|   |   | The      expected term of stock options represents the average period the stock      options are expected to remain outstanding and is based on the expected      term calculated using the approach prescribed by SAB 107 for “plain      vanilla” options. The Company used this approach as it did not have      sufficient historical information to develop reasonable expectations about      future exercise patterns and post-vesting employment termination behavior.      The expected stock price volatility for the Company’s stock options was      determined by examining the historical volatilities for industry peers for      periods that meet or exceed the expected term of the options, using an      average of the historical volatilities of the Company’s industry peers as      the Company did not have sufficient trading history for the Company’s      common stock. The Company will continue to analyze the historical stock      price volatility and expected term assumption as more historical data for      the Company’s common stock becomes available. The risk-free interest rate      assumption is based on the U.S. Treasury instruments whose term was      consistent with the expected term of the Company’s stock options. The      expected dividend assumption is based on the Company’s history and      expectation of dividend payouts. The      Company accounts for its issuances of stock-based compensation to      non-employees for services using the measurement date guidelines      enumerated in SFAS 123R and EITF 96-18. Accordingly, the value      of any awards that were vested and non forfeitable at their date of      issuance were measured based on the fair value of the equity instruments      at the date of issuance. The non-vested portion of awards that are subject      to the future performance of the counterparty are adjusted at each      reporting date to their fair values based upon the then current market      value of the Company’s stock and other assumptions that management      believes are reasonable. The Company believes that the fair value of the      stock options issued to non-employees is more reliably measurable      than the fair value of the services rendered. The fair value of the stock      options granted was calculated using the Black-Scholes option pricing      model as prescribed bySFAS 123R. |

----

----

| Twelve months ending December      31,  |   | Expected amortization expense |   |
|-------------------------------------------------------------|--------|-----------------------------------------|--------|
| 2009                                                        |   | $                                       | 32,727 |   |
| 2010                                                        |   |                                    | 10,909 |   |
| Total                                                       |   | $                                       | 43,636 |   |

| Twelve months ending December      31, |   | Expected amortization expense |   |
|-------------------------------------------------------|--------|-----------------------------------------|--------|
| 2009                                                  |   | $                                       | 34,515 |   |
| 2010                                                  |   |                                    | 11,504 |   |
| Total                                                 |   | $                                       | 46,019 |   |

----

|                                               |   | December      31, 2008 |    |   | December      31, 2007               |   |
|----------------------------------------------------|--------|------------------------|---------|--------|--------------------------------------|--------|
|                                               |   | Number                 |    |   | Weighted      Average Exercise Price |   |   | Number |   |   | Weighted      Average Exercise Price |   |
|                                               |   |                   |    |   |                                 |   |   |   |   |   |   |   |
| Outstanding,      beginning of  the year |   |                   | 50,000  |   |                                 | $      | 0.18 |   |   |   | - |   |   | $ | - |   |
| Granted                                            |   |                   | 525,000 |   |                                 |   | 0.19 |   |   |   | 50,000 |   |   |   | 0.18 |   |
|                                               |   |                   |    |   |                                 |   |   |   |   |   |   |   |   |   |   |   |
| Outstanding,      end of the year                  |   |                   | 575,000 |   |                                 | $      | 0.19 |   |   |   | 50,000 |   |   | $ | 0.18 |   |
|                                               |   |                   |    |   |                                 |   |   |   |   |   |   |   |   |   |   |   |
| Exercisable,      end of the year                  |   |                   | 308,334 |   |                                 | $      | 0.19 |   |   |   | 50,000 |   |   | $ | 0.18 |   |

| Range      of Exercise Prices |               |   | Remaining      Number Outstanding |   |    | Weighted      Average Contractual Life (Years) |   |   | Weighted      Average Exercise Price |   |
|------------------------------------|--------------------|--------|-----------------------------------|--------|---------|------------------------------------------------|--------|--------|--------------------------------------|--------|
|                               |               |   |                              |   |    |                                           |   |   |                                 |   |
| $                                  | 0.18      to $0.19 |   |                              |   | 575,000 |                                           |   |   | 8.8                                  |   |   | $ | 0.19 |   |

----

|                                  |   | December      31,  |     |
|---------------------------------------|--------|-------------------------|----------|
|                                  |   | 2008               |     |   | 2007  |   |
| Net      operating loss carryforwards |   | $                       | 374,844  |   |   | $ | 137,841 |   |
|                                  |   |                    |     |   |   |   |   |   |
| Amortization                          |   |                    | 80,608   |   |   |   | 72,108 |   |
|                                  |   |                    |     |   |   |   |   |   |
| Stock      based compensation         |   |                    | 12,013   |   |   |   | 596 |   |
|                                  |   |                    |     |   |   |   |   |   |
| Less:      Valuation allowance        |   |                    | (467,465 | ) |   |   | (210,545 | ) |
|                                  |   |                    |     |   |   |   |   |   |
| Net      deferred tax assets          |   | $                       | -        |   |   | $ | - |   |

|                                            |   |                                  |     |   |                           |   |    |   |   | For      the period April   |     |
|-------------------------------------------------|--------|---------------------------------------|----------|--------|--------------------------------|--------|---------|--------|--------|-----------------------------|----------|
|                                            |   |                                  |     |   |                           |   |    |   |   | 10,      2000 (Commencement |     |
|                                            |   |                                  |     |   |                           |   |    |   |   | of      Predecessor         |     |
|                                            |   | For      the years ended December 31, |     |   | Business)      to December 31. |   |
|                                            |   | 2008                                  |     |   | 2007                           |   |    | 2008   |   |
|                                            |   |                                  |     |   |                           |   |
| At      Statutory Rates                         |   | $                                     | (218,383 | )      |                           | $      | (97,425 | )      |   | $                           | (608,738 | ) |
| State      income taxes, net of federal benefit |   |                                  | (38,538  | )      |                           |   | (17,193 | )      |   |                        | (107,424 | ) |
| NOL’s      utilized by Sentigen           |   |                                  | —  |   |                           |   | — |   |   |                        | 297,895  |   |
| Increase      in valuation allowance            |   |                                  | 256,921  |   |                           |   | 114,618 |   |   |                        | 418,267  |   |
|                                            |   |                                  |     |   |                           |   |    |   |   |
| Provision      for income taxes                 |   | $                                     | —  |   |                           | $      | — |   |   | $                           | —  |   |

----

----

----

| ITEM      9 |   | CHANGES      IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL      DISCLOSURE. |
|-------------|--------|-------------------------------------------------------------------------------------------------|

| ITEM  9A |   | CONTROLS      AND PROCEDURES. |
|--------------------|--------|-------------------------------|

|   | • |   | Pertain      to the maintenance of records that, in reasonable detail, accurately and      fairly reflect the transactions and dispositions of the assets of the      Company;                                                                                                                                                                 |
|--------|---------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |    |   |                                                                                                                                                                                                                                                                                                                                           |
|   | • |   | Provide      reasonable assurance that transactions are recorded as necessary to permit      preparation of financial statements in accordance with generally accepted      accounting principles, and that our receipts and expenditures are being      made only in accordance with authorizations of our management and      directors; and |
|   |    |   |                                                                                                                                                                                                                                                                                                                                           |
|   | • |   | Provide      reasonable assurance regarding prevention or timely detection of      unauthorized acquisition, use or disposition of our assets that could have      a material effect on the financialstatements.                                                                                                                               |

----

| ITEM      9B |   | OTHER      INFORMATION. |
|--------------|--------|-------------------------|

PARTIII

| ITEM      10 |   | DIRECTORS,      EXECUTIVE OFFICERS AND CORPORATEGOVERNANCE. |
|--------------|--------|-------------------------------------------------------------|

| Name                    |   | Age |   | Position                                                                                       |
|-------------------------|--------|-----|--------|------------------------------------------------------------------------------------------------|
| Joseph      K. Pagano   |   | 64  |   | Chief      Executive Officer, Secretary, Treasurer and Chairman of the Board of      Directors |
| Frederick      R. Adler |   | 83  |   | Director                                                                                       |
| Erik      R. Lundh      |   | 39  |   | Director                                                                                       |

----

| ITEM      11 |   | EXECUTIVE      COMPENSATION. |
|--------------|--------|------------------------------|

|                        |   | Option      awards (1) |    |   | Total  |   |
|-----------------------------|--------|------------------------|---------|--------|--------|--------|
| Name                        |   | ($)                    |    |   | ($)    |   |
| Joseph      K. Pagano       |   |                   | — |   |   |   | — |   |
| Frederick      R. Adler (2) |   | $                      | 6,990   |   |   | $      | 6,990 |   |
| Erik      R. Lundh          |   |                   | — |   |   |   | — |   |

|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|--------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)    |   | The      amounts in this column represent the dollar amount recognized in      accordance with SFAS 123R for financial statement reporting purposes with      respect to the 2008 fiscal year for the fair value of stock options      granted in 2008. Assumptions used in the calculation of these amounts for      the 2008 fiscal year are included in Note 8 to our audited financial      statements for the 2008 fiscal year included elsewhere    herein. |

|   |   |                                                                                                                                                                                                                                                                                                          |
|--------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)    |   | On      May 14, 2008 we granted 100,000 ten-year options  at $0.19      granted to Frederick R. Adler.  The options vested on June      24, 2008 and were granted at an exercise price equal to the closing      price of our common stock on the grant date.    |

| ITEM      12 |   | SECURITY      OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED      STOCKHOLDER MATTERS. |
|--------------|--------|-----------------------------------------------------------------------------------------------------------|

----

| Name and Address of Beneficial      Owner                                                                              |   | Amount      and Nature of Beneficial Ownership |                                                                        | Percentage      of Common Stock |
|------------------------------------------------------------------------------------------------------------------------|--------|-----------------------------------------------------|-----------------------------------------------------------------------------|---------------------------------|
|                                                                                                                   |   |                                                |                                                                        |                            |   |   |   |   |
| Joseph      K. Pagano                                                                                                  |   |                                                | 1,315,265                                                                   | (1)                             |   |   | 10.3 | % |
| 1217      South Flagler Drive, 3rd      FloorWest      Palm Beach, Florida 33401                                  |   |                                                |                                                                        |                            |   |   |   |   |
|                                                                                                                   |   |                                                |                                                                        |                            |   |   |   |   |
| Frederick      R. Adler                                                                                                |   |                                                |            1,611,941 |  (2)                       |   |   | 12.5 | % |
| 1520 S. Ocean      BoulevardPalm      Beach, Florida 33480                                              |   |                                                |                                                                        |                            |   |   |   |   |
|                                                                                                                   |   |                                                |                                                                        |                            |   |   |   |   |
| Erik      R. Lundh                                                                                                     |   |                                                | 55,000                                                                      | (3)                             |   |   | * |   |
| c/o Heidrick      & StrugglesOne      California Street, Ste. 2400San Francisco,      CA 94111      |   |                                                |                                                                        |                            |   |   |   |   |
|                                                                                                                   |   |                                                |                                                                        |                            |   |   |   |   |
| Samuel      A. Rozzi                                                                                                   |   |                                                | 1,628,777                                                                   | (4)                             |   |   | 12.8 | % |
| c/o Corporate      National Realty Inc.135      Crossways Park Drive, Suite 104Woodbury,      New York 11797 |   |                                                |                                                                        |                            |   |   |   |   |
|                                                                                                                   |   |                                                |                                                                        |                            |   |   |   |   |
| The      Joseph A. Pagano, Jr. 2007 Trust                                                                              |   |                                                | 1,128,157                                                                   |                            |   |   | 8.8 | % |
| 1217      South Flagler Drive, 3rd      FloorWest      Palm Beach, Florida 33401                                  |   |                                                |                                                                        |                            |   |   |   |   |
|                                                                                                                   |   |                                                |                                                                        |                            |   |   |   |   |
| Longview      Partners, L.P.                                                                                      |   |                                                | 1,260,458                                                                   | (5)                             |   |   | 9.9 | % |
| c/o Adler      & Co.400      Madison Ave. Suite 7CNew      York, NY 10017                                |   |                                                |                                                                        |                            |   |   |   |   |
|                                                                                                                   |   |                                                |                                                                        |                            |   |   |   |   |
| Susan      Chapman                                                                                                     |   |                                                | 1,287,525                                                                   | (6)                             |   |   | 10.1 | % |
| c/o Adler      & Co.400      Madison Ave., Suite 7CNew      York, NY 10017                               |   |                                                |                                                                        |                            |   |   |   |   |
|                                                                                                                   |   |                                                |                                                                        |                            |   |   |   |   |
| Executive      officer and all directors as a group (3 persons)                                                   |   |                                                | 2,982,206                                                                   | (1)(2)                          |   |   | 23.1 | % |

| *  |   | Represents      less than 1%.                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|---------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| (1)     |   | Includes      25,000 shares of Common Stock held of record by the Joseph Pagano,      Jr. Trust. Mr. Pagano disclaims beneficial ownership of all shares      other than those held in his name except to the extent of his pecuniary      interest therein. Does not include the shares of Common Stock held of      record by The Joseph A. Pagano Jr. 2007 Trust, a trust for which      Mr. Pagano has no investment control or right to    revoke. |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| (2)     |   | Includes      100,000 shares issuable upon the exercise of stock options to      purchase share of our Common Stock that are exercisable within      60 days of March 15, 2009                                                                                                                                                                                                                                                                                    |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| (3)     |   | Includes      2,500 shares held of record by each of Mr. Lundh’s son and      daughter. Mr. Lundh disclaims beneficial ownership of these shares.      Includes 50,000 shares issuable upon the exercise of stock options to      purchase share of our Common Stock that are exercisable within      60 days of March 15, 2009.                                                                                                             |

----

| (4)    |   | Includes      150,000 shares held by Scarsdale Limited Partnership, of which      Mr. Rozzi is general partner. Mr. Rozzi’s daughter and The      Samuel A. Rozzi Grantor Retained Annuity Trust, of which Mr. Rozzi’s      daughter is trustee, are the sole limited partners of Scarsdale Limited      Partnership. Mr. Rozzi disclaims beneficial ownership of all shares      other than those held in his name except to the extent of his pecuniary      interest therein. |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (5)    |   | Susan      Chapman is the general partner of Longview Partners, L.P., which is the      registered holder of these shares. Mrs. Chapman is an adult daughter      of Frederick R. Adler.                                                                                                                                                                                                                                                                                                                         |
|   |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (6)    |   | Includes      the shares held of record by Longview Partners, L.P. (of which      Mrs. Chapman is the general partner), 300 shares held in trusts      for the benefit of Mrs. Chapman’s children and 26,767 shares      held of record by Mrs. Chapman’sspouse.                                                                                                                                                                                                                 |

| ITEM      13 |   | CERTAIN      RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR      INDEPENDENCE. |
|--------------|--------|--------------------------------------------------------------------------------------|

----

| ITEM      14 |   | PRINCIPAL      ACCOUNTANT FEES AND SERVICES. |
|--------------|--------|----------------------------------------------|

|                              |   |                   |   |   |                   |   |
|-----------------------------------|--------|------------------------|--------|--------|------------------------|--------|
|                              |   | December      31, 2007 |   |   | December      31, 2008 |   |
| (i) Audit      Fees          |   | $                      | 35,000 |   |                   | $      | 35,000 |   |
| (ii) Audit      Related Fees |   | $                      | 0      |   |                   | $      |   |   |
| (iii) Tax      Fees          |   | $                      | 0      |   |                   | $      |   |   |
| (iv) All      Other Fees     |   | $                      | 0      |   |                   | $      |   |   |
| Total      Fees                   |   | $                      | 35,000 |   |                   | $      | 35,000 |   |

----

| ITEM      15 |   | EXHIBITS      AND FINANCIAL STATEMENT SCHEDULES |
|--------------|--------|-------------------------------------------------|

|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|-------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Exhibit     |   | Description                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 3.1         |   | Certificate      of Incorporation of SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 3.1.1       |   | Certificate      of Amendment to Certificate of Incorporation of SentiSearch, Inc. dated      June 24, 2008, incorporated by reference to Exhibit 3.1 to      SentiSearch’s  Form 8-K filed on June 26,  2008.                                                                                                                                                                                                                                                                                                                                                                |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 3.2         |   | Bylaws      of SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 4.1         |   | Specimen      Common Stock Certificate of SentiSearch, Inc.(2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.1        |   | Exclusive      License Agreement dated April 10, 2000 between Sentigen Biosciences,      Inc. (formerly known as Sentigen Corp.), and The Trustees of Columbia      University in the City of New York.(1)                                                                                                                                                                                                                                                                                                                                                                               |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.2        |   | Consent      to the Assignment to SentiSearch, Inc. of the Exclusive License Agreement      dated April 10, 2000 between Sentigen Biosciences, Inc. (formerly      known as Sentigen Corp.), and The Trustees of Columbia University in the      City of New York: (1) Letter dated September 25, 2006 by      Sentigen Biosciences, Inc. requesting consent to assignment of the      Exclusive License Agreement, and (2) Letter dated October 17,      2006 by Columbia University granting consent to the assignment of the      Exclusive License Agreement.(1) |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.3        |   | Separation      and Distribution Agreement, dated as of October 10, 2006, between      Sentigen Holding Corp. and SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.4        |   | Contribution      Agreement, dated as of October 10, 2006, between Sentigen Holding      Corp. and SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.5        |   | Patent      Assignment, dated October 10, 2006, by Sentigen Holding Corp. to      SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.6        |   | Form      of Indemnification Agreement.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.7        |   | Option      Agreement dated May 16, 2007 by and between Erik R. Lundh and      SentiSearch, Inc., incorporated by reference to Exhibit 10.1 to      SentiSearch’s Form 8-K filed on May 18, 2007.                                                                                                                                                                                                                                                                                                                                                                   |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.8        |   | Form      of Demand Promissory Note, incorporated by reference to Exhibit 10.1      to SentiSearch’s Form 8-K filed on June 22,  2007.                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.9        |   | Revolving      Credit Note, dated as of March 10, 2008, incorporated by reference to      Exhibit 10.1 to SentiSearch’s  Form 10-Q filed on May 15,      2008.                                                                                                                                                                                                                                                                                                                                                                                                                |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.10       |   | Form      of Subscription Agreement, incorporated by reference to Exhibit 10.1 to      SentiSearch’s Form 8-K filed on May 15, 2008.                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.11       |   | Revolving      Credit Note dated as of March 10, 2008, incorporated by reference to      Exhibit 10.1 to SentiSearch’s Form 8-K filed on May 15,    2008.                                                                                                                                                                                                                                                                                                                                                                                                                               |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|  10.12 |   | Form      of Subscription Agreement, incorporated by reference to Exhibit 10.1 to      SentiSearch’s Form 8-K filed on June 26, 2008                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 31          |   | Certification      of Chief Executive and Financial Officer pursuant to Rule 13a-14 and      Rule 15d-14(a), promulgated under the Securities and Exchange Act of      1934, as amended.                                                                                                                                                                                                                                                                                                                                                                                            |
|        |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 32          |   | Certification      of Chief Executive and Financial Officer pursuant to 18 U.S.C.      Section 1350, as adopted pursuant to Section 906 of the      Sarbanes-Oxley Act of 2002.                                                                                                                                                                                                                                                                                                                                                                                                     |

| (1)    |   | Incorporated      by reference to the applicable exhibit filed with SentiSearch’s      Registration Statement on Form 10-SB filed with the SEC on      November 15, 2006. File No. 000-52320.                          |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                   |
| (2)    |   | Incorporated      by reference to the applicable exhibit filed with SentiSearch’s      Registration Statement on Amendment No. 1 to Form 10-SB filed with      the SEC on November 29, 2006. File  No. 000-52320. |

----

|                      |                                                                                  |                 |
|---------------------------|---------------------------------------------------------------------------------------|----------------------|
|                      | SENTISEARCH,      INC.                                                                |
|            |                                                                        |       |
| Date:      March 30, 2009 | By:                                                                         | /s/ Joseph K. Pagano |
|                      | /Joseph      K. Pagano,Chief      Executive Officer(Principal      Executive Officer) |

| Name                        |         | Title                                                                                                                                                             |   | Date                |
|-----------------------------|--------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------------|
|                        |         |                                                                                                                                                              |   |                |
| /s/      Joseph K. Pagano   |         |                                                                                                                                                              |   |                |
| Joseph      K. Pagano       |    | Chief      Executive Officer, Secretary and Treasurer Chairman of the Board,      Principal Executive Officer and Principal Financial and Accounting      Officer |   | March      30, 2009 |
|                        |         |                                                                                                                                                              |   |                |
| /s/      Frederick R. Adler |         |                                                                                                                                                              |   |                |
| Frederick      R. Adler     |    | Director                                                                                                                                                          |   | March      30, 2009 |
|                        |         |                                                                                                                                                              |   |                |
| /s/      Erik R. Lundh      |         |                                                                                                                                                              |   |                |
| Erik      R. Lundh          |    | Director                                                                                                                                                          |   | March      30, 2009 |
|                        |         |                                                                                                                                                              |   |                |

----

|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|---------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Exhibit |   | Description                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 3.1     |   | Certificate      of Incorporation of SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 3.1.1   |   | Certificate      of Amendment to Certificate of Incorporation of SentiSearch, Inc. dated      June 24, 2008, incorporated by reference to Exhibit 3.1 to      SentiSearch’s  Form 8-K filed on June 26,  2008.                                                                                                                                                                                                                                                                                                                                                                |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 3.2     |   | Bylaws      of SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 4.1     |   | Specimen      Common Stock Certificate of SentiSearch, Inc.(2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.1    |   | Exclusive      License Agreement dated April 10, 2000 between Sentigen Biosciences,      Inc. (formerly known as Sentigen Corp.), and The Trustees of Columbia      University in the City of New York.(1)                                                                                                                                                                                                                                                                                                                                                                               |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.2    |   | Consent      to the Assignment to SentiSearch, Inc. of the Exclusive License Agreement      dated April 10, 2000 between Sentigen Biosciences, Inc. (formerly      known as Sentigen Corp.), and The Trustees of Columbia University in the      City of New York: (1) Letter dated September 25, 2006 by      Sentigen Biosciences, Inc. requesting consent to assignment of the      Exclusive License Agreement, and (2) Letter dated October 17,      2006 by Columbia University granting consent to the assignment of the      Exclusive License Agreement.(1) |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.3    |   | Separation      and Distribution Agreement, dated as of October 10, 2006, between      Sentigen Holding Corp. and SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.4    |   | Contribution      Agreement, dated as of October 10, 2006, between Sentigen Holding      Corp. and SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.5    |   | Patent      Assignment, dated October 10, 2006, by Sentigen Holding Corp. to      SentiSearch, Inc.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.6    |   | Form      of Indemnification Agreement.(1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.7    |   | Option      Agreement dated May 16, 2007 by and between Erik R. Lundh and      SentiSearch, Inc., incorporated by reference to Exhibit 10.1 to      SentiSearch’s Form 8-K filed on May 18, 2007.                                                                                                                                                                                                                                                                                                                                                                   |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.8    |   | Form      of Demand Promissory Note, incorporated by reference to Exhibit 10.1      to SentiSearch’s Form 8-K filed on June 22,  2007.                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.9    |   | Revolving      Credit Note, dated as of March 10, 2008, incorporated by reference to      Exhibit 10.1 to SentiSearch’s  Form 10-Q filed on May 15,      2008.                                                                                                                                                                                                                                                                                                                                                                                                                |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.10   |   | Form      of Subscription Agreement, incorporated by reference to Exhibit 10.1 to      SentiSearch’s Form 8-K filed on May 15, 2008.                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.11   |   | Revolving      Credit Note dated as of March 10, 2008, incorporated by reference to      Exhibit 10.1 to SentiSearch’s Form 8-K filed on May 15,    2008.                                                                                                                                                                                                                                                                                                                                                                                                                               |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.12   |   | Form      of Subscription Agreement, incorporated by reference to Exhibit 10.1 to      SentiSearch’s Form 8-K filed on June 26, 2008                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 31      |   | Certification      of Chief Executive and Financial Officer pursuant to Rule 13a-14 and      Rule 15d-14(a), promulgated under the Securities and Exchange Act of      1934, as amended.                                                                                                                                                                                                                                                                                                                                                                                            |
|    |   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 32      |   | Certification      of Chief Executive and Financial Officer pursuant to 18 U.S.C.      Section 1350, as adopted pursuant to Section 906 of the      Sarbanes-Oxley Act of 2002.                                                                                                                                                                                                                                                                                                                                                                                                     |

|   |   |                                                                                                                                                                                                                                   |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (1)    |   | Incorporated      by reference to the applicable exhibit filed with SentiSearch’s      Registration Statement on Form 10-SB filed with the SEC on      November 15, 2006. File No. 000-52320.                          |
|   |   |                                                                                                                                                                                                                                   |
| (2)    |   | Incorporated      by reference to the applicable exhibit filed with SentiSearch’s      Registration Statement on Amendment No. 1 to Form 10-SB filed with      the SEC on November 29, 2006. File  No. 000-52320. |

----